Related Experiment Video

Updated: May 25, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

The Impact of Maternal Smoking during Pregnancy on Early Child Neurodevelopment

George L Wehby1, Kaitlin Prater, Ann Marie McCarthy

  • 1Dept. of Health Management and Policy, College of Public Health, University of Iowa, 200 Hawkins Drive, E205 GH, Iowa City, IA 52242, .

Journal of Human Capital
|January 25, 2012
PubMed

Insights

Maternal smoking during pregnancy significantly harms child neurodevelopment, especially in low socioeconomic status (SES) families. Early interventions before and during pregnancy are crucial for child development and future potential.

Area of Science:

  • Pediatrics
  • Neuroscience
  • Public Health

Background:

  • Early child neurodevelopment is critical for long-term human capital and health.
  • Prenatal risk factors' impact on neurodevelopment requires further investigation.

Purpose of the Study:

  • To evaluate maternal smoking's effects on child neurodevelopment from 3 to 24 months.
  • To examine the interaction between maternal smoking and socioeconomic status (SES) on neurodevelopment.

Main Methods:

  • Utilized data from a unique South American child sample.
  • Assessed neurodevelopmental outcomes between 3 and 24 months of age.

Main Results:

  • Maternal smoking during pregnancy demonstrated significant adverse effects on child neurodevelopment.
  • These adverse effects were more pronounced in children from low socioeconomic status (SES) backgrounds.

Conclusions:

  • Maternal smoking poses a substantial risk to early child neurodevelopment.
  • Targeted early interventions, particularly for vulnerable low SES populations, are essential to mitigate these risks and support child development.

More Related Videos

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...